Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra]; Drug: rituximab [MabThera/Rituxan]; Drug: Placebo
Sponsor: Hoffmann-La Roche
Active, not recruiting - verified July 2011
By ClinicalTrials.gov 
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.